Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumoniaSara De Biasi, Andrea Cossarizza, Marco Sita et al.|Nature Communications|2020Cited by 846
Molecular and cellular immune features of aged patients with severe COVID-19 pneumoniaDomenico Lo Tartaro, Sara De Biasi, Anita Neroni et al.|Communications Biology|2022Cited by 46
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state studyJovana Milić, Roberto D’Amico, Federico Banchelli et al.|PLoS ONE|2021Cited by 6
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort StudyCristina Mussini, Giovanni Guaraldi, Alessandro Cozzi‐Lepri et al.|Viruses|2023Cited by 5
Molecular and cellular immune features of aged patients with severe COVID-19 pneumoniaDomenico Lo Tartaro, Andrea Cossarizza, Anita Neroni et al.|Research Square|2022Cited by 2